Video Experimental Relacionado
Updated: Jan 8, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Polymersome-based nanomedicine for combined cancer therapy
Aidin Mohammadi Zonouz1,2, Mehrshad Ebrahimpour2, Kimia Zibaei2
1Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Polymersomes offer a promising platform for cancer combination therapy, enabling simultaneous delivery of multiple treatments. This nanomedicine approach enhances treatment efficacy and precision while minimizing side effects for improved patient outcomes.
Más Videos Relacionados
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
09:09Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
Videos de Conceptos Relacionados
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...